“We has great potential for new drug development” Hoyoung Huh, CEO of pH Pharma, aiming for a special listing onto KOSDAQ

Hoyoung Huh, CEO of pH Pharma, which is targeting to go IPO onto KOSDAQ through special listing for tech company, gave the keynote speech at the Biomedical Innovation Summit held in Madrid, Spain.

(For more information, please refer to the link below)